The Scientist

» neuroimaging and immunology

Most Recent

A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro. 

1 Comment

image: Image of the Day: Red Alert

Image of the Day: Red Alert

By | November 9, 2017

Researchers unveil the neural basis of alertness in larval zebrafish.   

0 Comments

image: Image of the Day: Fragile X

Image of the Day: Fragile X

By | November 7, 2017

Researchers uncover the central role of a protein linked to Fragile X Syndrome in mice, one of the leading causes of autism and intellectual disability.

0 Comments

image: Image of the Day: Tadpole Prism

Image of the Day: Tadpole Prism

By | November 3, 2017

Scientists are making use of Xenopus tadpoles to study autism risk genes. 

0 Comments

image: Image of the Day: Fish Eye Lens

Image of the Day: Fish Eye Lens

By | November 1, 2017

Researchers develop a new method to highlight specific cells that reside in the lens of a zebrafish.

0 Comments

image: Lighting Up Monkey Brains

Lighting Up Monkey Brains

By | November 1, 2017

Optogenetic and chemogenetic tools illuminate brain and behavior connections in nonhuman primates.

2 Comments

image: Image of the Day: Painting with Viruses

Image of the Day: Painting with Viruses

By | October 31, 2017

Researchers have used a modified rabies virus and fluorescent proteins to tag individual nerve cells in the mouse visual cortex. 

0 Comments

image: Image of the Day: Fear Center

Image of the Day: Fear Center

By | October 26, 2017

A set of neurons in the brain’s central amygdala plays a key role in forming memories of aversive experiences, scientists find in mice.  

0 Comments

image: Image of the Day: CRISPR on a Mouse Canvas

Image of the Day: CRISPR on a Mouse Canvas

By | October 25, 2017

Scientists are using CRISPR-Cas9 technology to tag and explore specific sets of neurons in mice, in one of the first steps towards building a comprehensive atlas of brain circuitry. 

0 Comments

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 

0 Comments

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Researchers Build a Cancer Immunotherapy Without Immune Cells
  3. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech